Results for tag: "Neurodegenerative Disease Drug"

The Neurodegenerative Disease Drug market is a subset of the Central Nervous System Drugs market, which focuses on treatments for diseases that cause the progressive loss of structure or function of neurons, including Alzheimer's disease, Parkinson's disease, Huntington's disease, and amyotrophic lateral sclerosis (ALS). These drugs are typically used to slow the progression of the disease, improve symptoms, and improve quality of life. Common treatments include cholinesterase inhibitors, glutamate antagonists, and dopamine agonists. The Neurodegenerative Disease Drug market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Pfizer, Novartis, Merck, Sanofi, and Johnson & Johnson. Show Less Read more